|
|
|||||||
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
08-20-2015, 04:26 PM
|
|||
|
|||
Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial
FRANKFURT (Reuters) - A clinical trial showed that diabetes drug Jardiance, co-promoted by Eli Lilly and Boehringer Ingelheim, reduces cardiovascular risk in patients with type 2 diabetes, Boehringer Ingelheim said in a statement on Thursday.  ??????? ??????: Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري